Psychosocial risk associated with newborn screening for cystic fibrosis: Parents' experience while awaiting the sweat-test appointment

被引:111
|
作者
Tluczek, A
Koscik, RL
Farrell, PM
Rock, MJ
机构
[1] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA
[2] Univ Wisconsin, Sch Nursing, Madison, WI 53719 USA
[3] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53719 USA
[4] Univ Wisconsin, Sch Med, Madison, WI 53719 USA
关键词
cystic fibrosis; newborn screening; psychosocial risk;
D O I
10.1542/peds.2004-0275
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background. The psychosocial effects on parents of infants with abnormal results in cystic fibrosis (CF) newborn screening (NBS) that uses genetic testing remain unclear. Methods. Twenty-eight individuals representing 14 families participated in grounded theory interviews similar to 6 months after their child's positive NBS results for CF. Participants also completed the Center for Epidemiologic Studies Depression Scales (CES-D) at their infant's sweat-test appointment (n = 51) and/ or similar to 6 months after the sweat test (n = 35). Results. Most parents experienced high levels of emotional distress during their wait for the sweat-test appointment (CES-D score, mean +/- SD: 16.5 +/- 6.7; 43.1% in the clinical range; median wait: 7 days; range: 3-35 days). CES-D scores of these parents were also significantly higher than those of comparison parents. Interviews showed that parental cognitive uncertainty and emotional distress were influenced by the parents' prior knowledge of NBS, CF, and their carrier status; parents' adjustment to their new baby; and the physicians' approach to informing parents. Parents' coping strategies involved requesting a sweat test as soon as possible, searching for information, assessing the infant's risk/health, seeking support, praying, or not talking with others. Conclusions. The waiting period from notification regarding positive NBS results to diagnostic test results can be psychologically distressing to parents, causing depressive symptoms that vary depending on their perceptions about the likelihood that their infant has CF. Implications for future research examining psychosocial interventions for NBS are discussed.
引用
收藏
页码:1692 / 1703
页数:12
相关论文
共 10 条
  • [1] Parental Understanding of Newborn Screening for Cystic Fibrosis After a Negative Sweat-Test
    Lang, Colleen Walsh
    McColley, Susanna A.
    Lester, Lucille A.
    Ross, Lainie Friedman
    PEDIATRICS, 2011, 127 (02) : 276 - 283
  • [2] Parents' experience with positive newborn screening results for cystic fibrosis
    Brockow, Inken
    Nennstiel, Uta
    EUROPEAN JOURNAL OF PEDIATRICS, 2019, 178 (06) : 803 - 809
  • [3] Parents’ experience with positive newborn screening results for cystic fibrosis
    Inken Brockow
    Uta Nennstiel
    European Journal of Pediatrics, 2019, 178 : 803 - 809
  • [4] A sweat test centered protocol for the disclosure and diagnosis of cystic fibrosis in a newborn screening program
    Doull, I. J. M.
    Hall, S. J.
    Bradley, D. M.
    PEDIATRIC PULMONOLOGY, 2007, 42 (09) : 773 - 778
  • [5] Newborn Screening for Cystic Fibrosis: Infant and Laboratory Factors Affecting Successful Sweat Test Completion
    Shenoy, Ambika
    Spyropoulos, Dina
    Peeke, Kathleen
    Smith, Dawn
    Cellucci, Michael
    Chidekel, Aaron
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2021, 7 (01)
  • [6] Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening
    Annette Vernooij-van Langen
    Edward Dompeling
    Jan-Bart Yntema
    Bert Arets
    Harm Tiddens
    Gerard Loeber
    Jeannette Dankert-Roelse
    European Journal of Pediatrics, 2015, 174 : 1025 - 1034
  • [7] Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening
    Vernooij-van Langen, Annette
    Dompeling, Edward
    Yntema, Jan-Bart
    Arets, Bert
    Tiddens, Harm
    Loeber, Gerard
    Dankert-Roelse, Jeannette
    EUROPEAN JOURNAL OF PEDIATRICS, 2015, 174 (08) : 1025 - 1034
  • [8] Comparison of nanoduct versus macroduct sweat test for the diagnosis of cystic fibrosis in the newborn screening programme in Switzerland
    Barben, Juerg
    Rueegg, Corina S.
    Gallati, Sabina
    Kuehni, Claudia E.
    Baumgartner, Matthias
    Torresani, Toni
    Schoeni, Martin H.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [9] Sweat conductivity for diagnosing cystic fibrosis after positive newborn screening: prospective, diagnostic test accuracy study
    Bedran, Renata Marcos
    Alvim, Cristina Goncalves
    Sader, Olivia Goncalves
    Alves Junior, Jose Vicente
    Pereira, Fernando Henrique
    Nolasco, Daniela Magalhaes
    Zhang, Linjie
    Camargos, Paulo
    ARCHIVES OF DISEASE IN CHILDHOOD, 2023, 108 (07) : 538 - 542
  • [10] Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience
    Bianchimani, Chiara
    Dolce, Daniela
    Centrone, Claudia
    Campana, Silvia
    Ravenni, Novella
    Orioli, Tommaso
    Camera, Erica
    Mergni, Gianfranco
    Fevola, Cristina
    Bonomi, Paolo
    Taccetti, Giovanni
    Terlizzi, Vito
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2022, 8 (03)